Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety.
Mathon B, Le Joncour A, Bielle F, Mokhtari K, Boch AL, Peyre M, Amoura Z, Cacoub P, Younan N, Demeret S, Shotar E, Burrel S, Fekkar A, Robert J, Amelot A, Pineton de Chambrun M; PSL BRAIN-BIOPSY STUDY GROUP.
Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield.
Mathon B, Favreau M, Degos V, Amelot A, Le Joncour A, Weiss N, Rohaut B, Le Guennec L, Boch AL, Carpentier A, Bielle F, Mokhtari K, Idbaih A, Touat M, Combes A, Demoule A, Shotar E, Navarro V, Raux M, Demeret S, Pineton De Chambrun M; PSL BRAIN-BIOPSY STUDY GROUP.
Crit Care Med. 2022 Jun 1;50(6):e516-e525. doi: 10.1097/CCM.0000000000005439. Epub 2022 Jan 10.
PMID:34995211
Diagnostic Accuracy and Field for Improvement of Frameless Stereotactic Brain Biopsy: A Focus on Nondiagnostic Cases.
He Z, Zhu CXL, Chan DTM, Cheung TCY, Ng HK, Mok VCT, Poon WS.
J Neurol Surg A Cent Eur Neurosurg. 2024 Jan;85(1):48-61. doi: 10.1055/a-1994-8033. Epub 2022 Dec 8.
PMID:36481998
Severity, timeline, and management of complications after stereotactic brain biopsy.
Riche M, Marijon P, Amelot A, Bielle F, Mokhtari K, Chambrun MP, Joncour AL, Idbaih A, Touat M, Do CH, Deme M, Pasqualotto R, Jacquens A, Degos V, Shotar E, Chougar L, Carpentier A, Mathon B.